(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 208.06% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.48%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10%.
Femasys's revenue in 2024 is $1,049,126.On average, 2 Wall Street analysts forecast FEMY's revenue for 2024 to be $51,107,651, with the lowest FEMY revenue forecast at $44,441,436, and the highest FEMY revenue forecast at $57,773,867. On average, 2 Wall Street analysts forecast FEMY's revenue for 2025 to be $315,534,196, with the lowest FEMY revenue forecast at $264,426,544, and the highest FEMY revenue forecast at $366,641,847.
In 2026, FEMY is forecast to generate $722,173,335 in revenue, with the lowest revenue forecast at $722,173,335 and the highest revenue forecast at $722,173,335.